Literature DB >> 17595489

Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity.

Tiakumzuk Sangtam, Anand Vinekar, Bakthavatsalu Maheshwar, Mangat R Dogra, Kah-Guan Au Eong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17595489     DOI： 10.4103/0301-4738.33053

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN： 0301-4738            Impact factor:   1.848


× No keyword cloud information.
  3 in total

1.  Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease.

Authors:  Marcel N Menke; Carsten Framme; Mathias Nelle; Markus R Berger; Veit Sturm; Sebastian Wolf
Journal:  BMC Ophthalmol       Date:  2015-03-08       Impact factor: 2.209

2.  Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity.

Authors:  Odalis Arámbulo; Gabriel Dib; Juan Iturralde; Fahir Duran; Miguel Brito; João B Fortes Filho
Journal:  Clin Ophthalmol       Date:  2015-10-29

Review 3.  Changing paradigms of anti-VEGF in the Indian scenario.

Authors:  P Mahesh Shanmugam
Journal:  Indian J Ophthalmol       Date:  2014-01       Impact factor: 1.848
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.